Literature DB >> 6853720

Relative ion permeability of normal and cystic fibrosis nasal epithelium.

M Knowles, J Gatzy, R Boucher.   

Abstract

The raised transepithelial electric potential difference (PD) across respiratory epithelia in cystic fibrosis (CF) has suggested an abnormality in ion permeation. We characterized this abnormality further by measuring in the nasal epithelia of CF and normal subjects the concentration-PD relationship for amiloride, an inhibitor of cell Na+ permeability, and PD responses to superfusion with solutions of different composition. Amiloride was more efficacious in the CF subjects but the ED50 was not different from that of normals (approximately 2 X 10(-6) M). Na+ replacement by choline induced effects similar to those of amiloride, i.e. a greater depolarization in CF subjects. A 10-fold increase in the K+ concentration of the perfusate induced a small (less than 10 mV) depolarization in both subject populations. When Cl- in the perfusate was replaced by gluconate or SO2-(4) the nasal PD of normal subjects hyperpolarized (lumen became more negative) by approximately 35 mV. A significantly smaller response (less than 17 mV) was induced in CF homozygotes but not in heterozygotes (38 mV). The smaller response of CF subjects appears to reflect an absolute decrease in luminal surface Cl- permeability because pretreatment with amiloride did not increase the response to Cl- free solution (7 mV). Accordingly, three abnormalities (decreased Cl- permeability, raised PD, greater amiloride efficacy) have been identified in CF respiratory epithelia. Whereas "excessive" active Na+ transport can account for these abnormalities and the dessication of airway surface liquid, it is possible that a lower lumenal cell membrane Cl- permeability and inhibition of a potential path of Cl- secretion can also explain the observations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6853720      PMCID: PMC437005          DOI: 10.1172/jci110894

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

Review 1.  Cystic fibrosis.

Authors:  R E Wood; T F Boat; C F Doershuk
Journal:  Am Rev Respir Dis       Date:  1976-06

Review 2.  Control of mucus secretion and ion transport in airways.

Authors:  J A Nadel; B Davis; R J Phipps
Journal:  Annu Rev Physiol       Date:  1979       Impact factor: 19.318

3.  A hypothesis for pulmonary clearance and its implications.

Authors:  K H Kilburn
Journal:  Am Rev Respir Dis       Date:  1968-09

4.  Micropuncture studies of the sweat formation in cystic fibrosis patients.

Authors:  I J Schulz
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

Review 5.  A review. Cystic fibrosis at forty--quo vadis?

Authors:  P B Davis; P A di Sant'Agnese
Journal:  Pediatr Res       Date:  1980-02       Impact factor: 3.756

6.  Studies on pulmonary secretions. II. Osmolality and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy.

Authors:  J L Potter; L W Matthews; S Spector; J Lemm
Journal:  Am Rev Respir Dis       Date:  1967-07

7.  Amphotericin B and K+ transport across excised toad urinary bladder.

Authors:  J T Gatzy; L Reuss; A L Finn
Journal:  Am J Physiol       Date:  1979-08

8.  Modification of Na and Cl transport in canine tracheal mucosa by prostaglandins.

Authors:  F Al-Bazzaz; V P Yadava; C Westenfelder
Journal:  Am J Physiol       Date:  1981-02

9.  Airway transepithelial electric potential in vivo: species and regional differences.

Authors:  R C Boucher; P A Bromberg; J T Gatzy
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-01

10.  Effect of catecholamines on ion transport in dog tracheal epithelium.

Authors:  F J Al-Bazzaz; E Cheng
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-08
View more
  61 in total

1.  Characterization of primary rat nasal epithelial cultures in CFTR knockout rats as a model for CF sinus disease.

Authors:  Kiranya E Tipirneni; Do-Yeon Cho; Daniel F Skinner; Shaoyan Zhang; Calvin Mackey; Dong-Jin Lim; Bradford A Woodworth
Journal:  Laryngoscope       Date:  2017-08-03       Impact factor: 3.325

2.  In vivo retroviral gene transfer into human bronchial epithelia of xenografts.

Authors:  J F Engelhardt; J R Yankaskas; J M Wilson
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 3.  Cystic fibrosis transmembrane conductance regulator dysfunction and its treatment.

Authors:  Jeremy Hull
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

Review 4.  Pathophysiology of the exocrine pancreas in cystic fibrosis.

Authors:  P R Durie; G G Forstner
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

Review 5.  New insights into the pathogenesis of cystic fibrosis sinusitis.

Authors:  Eugene H Chang
Journal:  Int Forum Allergy Rhinol       Date:  2013-11-26       Impact factor: 3.858

6.  Properties and regulation of chloride channels in cystic fibrosis and normal airway cells.

Authors:  K Kunzelmann; H Pavenstädt; R Greger
Journal:  Pflugers Arch       Date:  1989-11       Impact factor: 3.657

Review 7.  The Evolution of Cystic Fibrosis Care.

Authors:  Jessica E Pittman; Thomas W Ferkol
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

8.  Characterization of two distinct Cl- conductances in fused human respiratory epithelial cells. II. Relation to cystic fibrosis gene product.

Authors:  U H Schröder; E Frömter
Journal:  Pflugers Arch       Date:  1995-06       Impact factor: 3.657

Review 9.  Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.

Authors:  James L Kreindler
Journal:  Pharmacol Ther       Date:  2009-11-10       Impact factor: 12.310

10.  Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. An in vitro electrophysiologic analysis.

Authors:  C U Cotton; M J Stutts; M R Knowles; J T Gatzy; R C Boucher
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.